Tenero D M, Bottorff M B, Burlew B S, Williams J B, Lalonde R L
Department of Clinical Pharmacy, University of Tennessee, Memphis 38163.
J Cardiovasc Pharmacol. 1990 Nov;16(5):702-7. doi: 10.1097/00005344-199011000-00003.
The elderly are reported to be less sensitive to the beta-blocking effects of propranolol. However, age-related changes in the stereoselective pharmacokinetics or protein binding of propranolol enantiomers could have confounded the results of previous studies because only 1-propranolol contributes significantly to the beta-blocking effects of the racemate. To avoid these confounding variables, we studied 10 young (mean 28 years) and 10 elderly (mean 64 years) subjects, and determined the cardiac beta-receptor sensitivity in terms of unbound, active 1-propranolol. The doses of isoproterenol required to increase heart rate (HR) by 25 beats/min were determined before and during a continuous infusion of propranolol. The serum concentration of 1-propranolol was determined by enantioselective high-performance liquid chromatography (HPLC), and the unbound fraction was determined by equilibrium dialysis. The apparent in vivo receptor dissociation constant for unbound 1-propranolol increased from 0.066 +/- 0.047 ng/ml in the young to 0.218 +/- 0.264 ng/ml in the older group (p less than 0.05). The unbound fraction was decreased in the older subjects (0.141 +/- 0.023 vs. 0.121 +/- 0.025, p less than 0.05) because of an increase in alpha 1-acid glycoprotein concentration (55 +/- 11 mg/dl vs. 72 +/- 19 mg/dl, p less than 0.05). Advancing age was associated with a decreased sensitivity to isoproterenol (rs = 0.76, p less than 0.05) and to unbound 1-propranolol (rs = 0.45, p less than 0.05). We conclude that the older subjects have (a) decreased sensitivity to the beta-blocking effects of 1-propranolol and to the agonist effects of isoproterenol, and (b) a lower unbound fraction of 1-propranolol.
据报道,老年人对普萘洛尔的β受体阻滞作用敏感性较低。然而,普萘洛尔对映体的立体选择性药代动力学或蛋白结合的年龄相关变化可能混淆了先前研究的结果,因为只有(-)-普萘洛尔对消旋体的β受体阻滞作用有显著贡献。为避免这些混杂变量,我们研究了10名年轻受试者(平均28岁)和10名老年受试者(平均64岁),并根据未结合的活性(-)-普萘洛尔测定心脏β受体敏感性。在持续输注普萘洛尔之前和期间,测定使心率(HR)增加25次/分钟所需的异丙肾上腺素剂量。采用对映体选择性高效液相色谱法(HPLC)测定(-)-普萘洛尔的血清浓度,通过平衡透析法测定未结合分数。未结合的(-)-普萘洛尔的体内表观受体解离常数从年轻人中的0.066±0.047 ng/ml增加到老年组中的0.218±0.264 ng/ml(p<0.05)。老年受试者的未结合分数降低(0.141±0.023对0.121±0.025,p<0.05),因为α1-酸性糖蛋白浓度增加(55±11 mg/dl对72±19 mg/dl,p<0.05)。年龄增长与对异丙肾上腺素的敏感性降低(rs=0.76,p<0.05)和对未结合的(-)-普萘洛尔的敏感性降低(rs=0.45,p<0.05)相关。我们得出结论,老年受试者:(a)对(-)-普萘洛尔的β受体阻滞作用和异丙肾上腺素的激动剂作用敏感性降低;(b)(-)-普萘洛尔的未结合分数较低。